Treatment of Cognitive Impairment With PDE4 Inhibitor
Country
USA
Applicant
Takeda GmbH
Patent num
20150051254
(International) Application No
14460905
patent date
15.08.2014
Description
This invention relates to the treatment of varying degrees of cognitive impairment associated with, for example, aging, Alzheimer's disease, schizophrenia with low dose administration of a PDE4 inhibitor, specifically roflumilast.